Kelpac Medical09.06.16
The Kelpac Medical division of PPC Industries, a diversified medical technology company that provides end to end components, tubing, packaging, and device assembly solutions to high tech medical device companies, has announced the acquisition of Xeridiem Medical Devices, a specialist in liquid injection molding, silicone injection molding, silicone extrusion, and silicone device assembly.
The acquisition of the Tucson, Ariz.-based Xeridiem will bring together the strengths of PPC’s high quality manufacturing processes and Xeridiem’s expertise in silicone and device assembly, amplifying the business’ leadership within the growing device manufacturing sector.
“The acquisition of Xeridiem allows PPC to provide a full range of custom silicone products and device assembly to new and existing customers. Through Xeridiem we will be able to streamline processes, ultimately providing customers with greater technical expertise, shorter lead times, better customer service, and higher quality products. This enables strategic and focused customer partnerships and success,” stated Jonathan Waldron, CEO and president of PPC.
Roger Prevot, chairman of PPC and an operating partner of Kohlberg & Company, PPC’s primary shareholder, noted, “The Xeridiem acquisition further broadens our global and comprehensive medical device platform. We look forward to our growing partnerships and the success they will bring to the industry. Xeridiem’s expertise in silicone will allow us to capture new markets and better serve existing customers.”
The acquisition of the Tucson, Ariz.-based Xeridiem will bring together the strengths of PPC’s high quality manufacturing processes and Xeridiem’s expertise in silicone and device assembly, amplifying the business’ leadership within the growing device manufacturing sector.
“The acquisition of Xeridiem allows PPC to provide a full range of custom silicone products and device assembly to new and existing customers. Through Xeridiem we will be able to streamline processes, ultimately providing customers with greater technical expertise, shorter lead times, better customer service, and higher quality products. This enables strategic and focused customer partnerships and success,” stated Jonathan Waldron, CEO and president of PPC.
Roger Prevot, chairman of PPC and an operating partner of Kohlberg & Company, PPC’s primary shareholder, noted, “The Xeridiem acquisition further broadens our global and comprehensive medical device platform. We look forward to our growing partnerships and the success they will bring to the industry. Xeridiem’s expertise in silicone will allow us to capture new markets and better serve existing customers.”